Patients with decompensated cirrhosis may have low baseline Hgb but the large majority of HCV patients have normal Hgb levels like you and me. The baseline Hgb levels in the Ion trials were 12-14 also. There's no evidence to suggest HCV patients are all walking around with anemia. More Gilead hype.
-
Wed news: Lilly’s 4.5B medicine foundry project. 5 FDA decisions to watch in Q4. Hurricane Helene and the health supply chain. Lundbeck taps Charles River for AI-enabled neuro drug discovery. Amgen tax evasion lawsuit. See more on our front page
HCV launch
- Thread starter Anonymous
- Start date
-
- Tags
- None
Patients with decompensated cirrhosis may have low baseline Hgb but the large majority of HCV patients have normal Hgb levels like you and me. The baseline Hgb levels in the Ion trials were 12-14 also. There's no evidence to suggest HCV patients are all walking around with anemia. More Gilead hype.
You are obviously a abbvie inexperienced hcv person. Many patients have a low hgb. But the studies are designed for patients to finish the trial. You are wrong
STOP THE NEGATIVITY!! Tomorrow is Txgiving! Give it a break!!!!
No, HCV does not cause anemia unless the patient is cirrhotic. As you should know, only 20% of patients with HCV develop cirrhosis and 4% of the cirrhotics develop HCC. So, the large majority of HCV patients are not anemic. Also, as you should know, we only had a 1% discontinuation rate due to AEs in over 2,700 patients studied. Even if someone does develop anemia, it can be treated through with a RBV dose reduction. Again, more Gilead hype.
Oh well I thought the cirrohtic patients were our clinical adv. ???
You are still naive and your 19 years here shows
To my bros and sisses: Be thankful that we are Abbvie HCV! Gobble Gobble!!
Thanks and hope your turkey day was great as well! The World's Most Lazy DM
Your point is? The Gilead site indicated we will be approved this coming week! Yahoo!!!
My MSL told me approval won't be much before the Dec. 21st PDUFA date.
Are doctors warehousing Harvoni and Sovaldi scripts in lieu of the pending Viekirax approval? No! Rxs for Harvoni have been accelerating weekly since launch! I bet you can't wait to get approval and kick Gilead's butt! 
Read in Seeking Alpha that Harvoni Rxs were up 46% last week! The rest of this month is vacation time for most of us so who care if we get approval this week or next week. If we get a deficiency letter from FDA, launch will be Summer 2015 and most patients will be cured with Harvoni. Merry Christmas!
Quit the negativity! We will be fine with a 5% market share. There is nothing close in the pipeline. Take the money and RELAX!
Hcv launch. "Houston we are the problem" Management abbvie
We are only 1 day away from the birth of 3D!! Celebrate! Celebrate!! Time to kick some Gilead Butt!!!
What is your strategy? What are the advantages 3D has over Harvoni that you will be pointing to?
It's gotta great fucking taste! Beat that! Folks want to taste mango or boisenberry while fighting for their liver.
A clear, patient centered advantage. Bam!
A clear, patient centered advantage. Bam!
Good luck with that. Gilead didn't get where they are today by lack of strategy.
It fills you up with all those pills. You won't be hungry